Methanolic extracts of leaves, flowers, stems, bark, and other parts o
f representative plants of the Myrtaceae, specifically of the Eucalypt
us, Melaleuca, Thryptomena, Callistomen, Acmena, and Angophora genera,
variously contain high levels of inhibitors of plant Ca2+-dependent p
rotein kinase (CDPK) and of Ca2+-calmodulin-dependent myosin light cha
in kinase (MLCK). In terms of the protein kinase inhibition unit (PKIU
), defined as the amount in the standard protein kinase assays causing
50 % inhibition of protein kinase activity, these inhibitor levels ra
nged from the non-detectable to 179,000 PKIU (gram fresh weight)-1 [(g
FW)-1] and there was no consistent pattern of inhibitor distribution.
A variety of other plants tested had low or non-detectable levels of
CDPK and MLCK inhibitors. Plants of the Eucalyptus, Melaleuca, Angopho
ra, and Grevillea genera contained inhibitors of the catalytic subunit
of the cyclic AMP-dependent protein kinase (cAK), inhibitor levels ra
nging from 20,000 to 9,600,000 PKIU (g FW)-1. In general, cAK inhibito
r levels found in the Myrtaceae were mostly much higher than levels of
CDPK and MLCK inhibitors and reversed phase HPLC of such plant extrac
ts revealed a multiplicity of components associated with cAK inhibitor
y activity. These in vitro screening procedures enable rapid detection
and quantitation of levels of bioactive plant defence compounds with
medicinal potential.